The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...
A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
PK, safety and acceptability data and practical guidance on the optimal dosing of new more child-friendly formulations of...
P1073 is a case controlled prospective, clinical, observational and pathogenesis study of HIV-infected infants and children...
This study is currently on hold. The study is designed to characterize the pharmacokinetics of DLM using a model-based...
